The Era of Provisional Stenting for Bifurcations Comes to an End

After the large studies which set provisional stenting as the preferred strategy to treat bifurcations comes the double kissing crush technique (DK crush) to break the mold once again. This time, the DK crush technique is tested against provisional stenting in the left main, with a 3-year follow-up.

Técnica Doble Crush Doble Kissing vs. stent provisional

The DKCRUSH-V, soon to be published in J Am Coll Cardiol Intv, randomized 482 patients with unprotected left main stenosis to DK crush vs provisional stenting and followed them up to 3 years. Primary end point was target vessel failure (death, target vessel MI and target vessel revascularization). Safety end point was stent thrombosis. Patients were classified according to lesion complexity using the Syntax score, among others.

After 3 years, target vessel failure rate occurred in 16.9% of the provisional stent group vs. 8.3% in the DK crush group (p=0.005). This difference was mainly driven by a higher rate of target vessel MI (5.8% vs 1.7%; p=0.017) and higher target vessel revascularization rate (10.3% vs 5%; p=0.029) in the provisional stenting arm. 


Read also: TAVR Offers Better Quality of Life to Low Risk Patients.


Definite or probable thrombosis at 3 years resulted 4.1% for the provisional stenting arm and 0.4% for the DK crush arm (0.006). 

It is worth mentioning that DK crush was associated with a significant reduction both in the efficacy and safety end points in unprotected left main complex lesions.

Conclusion

The provisional stenting technique to treat left main lesions resulted in more target vessel MI, more target vessel revascularization and more stent thrombosis compared against the double kissing crush technique. This is the first of several randomized studies needed to gather definite evidence. 

Original Title: Three-Year Outcomes of the DKCRUSH-V Trial Comparing DK Crush With Provisional Stenting for Left Main Bifurcation Lesions.

Reference: Xiang Chen et al. J Am Coll Cardiol Intv 2019. Online before print.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...